
Oncorus ONCR
Oncorus P/E | ONCR
P/E Jährlich Oncorus
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00011 | -0.00206 | -0.00407 | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.00011 | -0.00407 | -0.00208 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Scholar Rock Holding Corporation
SRRK
|
-13.5 | $ 48.09 | -4.54 % | $ 5.52 B | ||
|
Revolution Medicines
RVMD
|
-17.3 | $ 161.01 | 0.99 % | $ 30.6 B | ||
|
Entera Bio Ltd.
ENTX
|
-7.83 | $ 3.29 | 0.15 % | $ 152 M | ||
|
Flexion Therapeutics, Inc.
FLXN
|
-4.58 | - | - | $ 459 M | ||
|
Legend Biotech Corporation
LEGN
|
-23.3 | $ 15.21 | -5.53 % | $ 5.61 B | ||
|
CytomX Therapeutics
CTMX
|
-53.6 | $ 2.04 | -0.73 % | $ 281 M | ||
|
China SXT Pharmaceuticals
SXTC
|
-0.184 | $ 2.67 | 2.9 % | $ 1.81 M | ||
|
Krystal Biotech
KRYS
|
41.3 | $ 308.83 | -2.21 % | $ 8.94 B | ||
|
Kura Oncology
KURA
|
-2.64 | $ 6.91 | -6.05 % | $ 606 M | ||
|
Inhibikase Therapeutics
IKT
|
-3.32 | $ 1.31 | 0.38 % | $ 129 M | ||
|
Protara Therapeutics
TARA
|
-4.26 | $ 2.28 | -5.21 % | $ 97.7 M | ||
|
Heron Therapeutics
HRTX
|
-9.92 | $ 0.25 | -5.3 % | $ 41.7 M | ||
|
Inovio Pharmaceuticals
INO
|
-1.16 | $ 1.76 | 2.63 % | $ 82.5 M | ||
|
Corvus Pharmaceuticals
CRVS
|
-20.8 | $ 9.66 | -3.5 % | $ 763 M | ||
|
Aytu BioScience
AYTU
|
-1.93 | $ 2.66 | -0.37 % | $ 32.8 M | ||
|
Heat Biologics, Inc.
HTBX
|
-1.26 | - | -5.76 % | $ 99.8 M | ||
|
Innoviva
INVA
|
5.98 | $ 18.42 | 0.03 % | $ 1.24 B | ||
|
BioCardia
BCDA
|
-0.98 | $ 0.77 | -0.08 % | $ 5.13 M | ||
|
Bio-Techne Corporation
TECH
|
62.1 | $ 72.69 | -0.01 % | $ 11.3 B | ||
|
Kindred Biosciences, Inc.
KIN
|
-9.01 | - | 0.11 % | $ 419 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-2.42 K | $ 1.52 | -8.16 % | $ 9.72 B | ||
|
Shineco, Inc.
TYHT
|
-1.99 | - | -3.90 % | $ 97.2 M | ||
|
ORIC Pharmaceuticals
ORIC
|
-7.89 | $ 7.34 | -4.68 % | $ 644 M | ||
|
Millendo Therapeutics, Inc.
MLND
|
-0.0685 | - | -5.36 % | $ 20.2 M | ||
|
Certara
CERT
|
-676 | $ 10.56 | -1.12 % | $ 1.69 B | ||
|
Intec Pharma Ltd
NTEC
|
-1.14 | - | -12.45 % | $ 17.7 M | ||
|
Anika Therapeutics
ANIK
|
-19.4 | $ 13.26 | -0.15 % | $ 190 M | ||
|
Aprea Therapeutics
APRE
|
-0.394 | $ 0.23 | -52.81 % | $ 1.5 M | ||
|
Galectin Therapeutics
GALT
|
-5.78 | $ 2.68 | -4.63 % | $ 171 M | ||
|
Processa Pharmaceuticals
PCSA
|
-0.305 | $ 1.59 | -5.92 % | $ 2.08 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
37.7 | $ 63.61 | -2.11 % | $ 6.61 B | ||
|
Progenity, Inc.
PROG
|
-1.76 | - | -3.47 % | $ 164 M | ||
|
Genprex
GNPX
|
-0.102 | $ 1.46 | -12.87 % | $ 1.36 M | ||
|
Strongbridge Biopharma plc
SBBP
|
-3.36 | - | 1.52 % | $ 136 M | ||
|
Nektar Therapeutics
NKTR
|
-6.67 | $ 30.23 | -7.1 % | $ 510 M | ||
|
Innate Pharma S.A.
IPHA
|
-2.57 | $ 0.87 | -7.57 % | $ 77.9 M | ||
|
Seneca Biopharma, Inc.
SNCA
|
-0.0331 | - | -1.19 % | $ 28.7 M | ||
|
BioMarin Pharmaceutical
BMRN
|
33.5 | $ 60.42 | -1.64 % | $ 11.6 B | ||
|
Matinas BioPharma Holdings
MTNB
|
-0.265 | $ 0.75 | -9.23 % | $ 4.11 M | ||
|
Enanta Pharmaceuticals
ENTA
|
-3.49 | $ 7.6 | -4.82 % | $ 220 M | ||
|
Milestone Pharmaceuticals
MIST
|
-2.29 K | $ 0.38 | -5.66 % | $ 40.4 M | ||
|
Lipocine
LPCN
|
-1.86 | $ 1.47 | -2.33 % | $ 8.01 M | ||
|
Seres Therapeutics
MCRB
|
10.9 | $ 1.25 | -6.02 % | $ 11.1 M | ||
|
Oramed Pharmaceuticals
ORMP
|
1.82 K | $ 3.58 | -2.98 % | $ 148 M | ||
|
Madrigal Pharmaceuticals
MDGL
|
-34.3 | $ 378.19 | -4.68 % | $ 8.48 B | ||
|
CEL-SCI Corporation
CVM
|
-0.782 | $ 1.2 | -18.37 % | $ 9.62 M | ||
|
Inventiva S.A.
IVA
|
-0.996 | $ 3.14 | -9.13 % | $ 188 M | ||
|
MeiraGTx Holdings plc
MGTX
|
-5.7 | $ 7.98 | -1.97 % | $ 642 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
29.3 | $ 39.21 | 1.76 % | $ 44.9 B | ||
|
Eton Pharmaceuticals
ETON
|
-121 | $ 60.77 | -0.96 % | $ 1.64 B |